Monoclonal Gammopathy in Amyotrophic Lateral Sclerosis: No Impact on Clinical Progression and Immunotherapy Outcomes. [PDF]
Kim H +7 more
europepmc +1 more source
CIDP With and Without Monoclonal Gammopathy of Undetermined Significance (MGUS): Comparison of Clinical Phenotype, Diagnostic Features, and Treatment Response. [PDF]
van Veen R +16 more
europepmc +1 more source
Screening for monoclonal gammopathy of undetermined significance is contraindicated. [PDF]
Singh G.
europepmc +1 more source
Monoclonal Gammopathy in ANCA-Negative Pauci-Immune Crescentic GN: Is There an Association? [PDF]
Vargas-Brochero MJ +8 more
europepmc +1 more source
Impact of SARS-CoV-2 vaccination on monoclonal gammopathy of undetermined significance: results from the population-based iStopMM study. [PDF]
Palmason R +31 more
europepmc +1 more source
Monoclonal gammopathy in WHIM syndrome can mask hypogammaglobulinemia. [PDF]
Lew J, Adatia A.
europepmc +1 more source
Hypoalbuminemia: a new risk factor for progression in patients with monoclonal gammopathy of uncertain significance. [PDF]
Alejo E +8 more
europepmc +1 more source
Diagnosis and Management of Monoclonal Gammopathy of Undetermined Significance: A Review. [PDF]
Liu Y, Parks AL.
europepmc +1 more source

